1. Home
  2. JQC vs BVS Comparison

JQC vs BVS Comparison

Compare JQC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JQC
  • BVS
  • Stock Information
  • Founded
  • JQC 2003
  • BVS 2011
  • Country
  • JQC United States
  • BVS United States
  • Employees
  • JQC N/A
  • BVS N/A
  • Industry
  • JQC Finance Companies
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • JQC Finance
  • BVS Health Care
  • Exchange
  • JQC Nasdaq
  • BVS Nasdaq
  • Market Cap
  • JQC 752.6M
  • BVS 656.9M
  • IPO Year
  • JQC N/A
  • BVS 2021
  • Fundamental
  • Price
  • JQC $5.34
  • BVS $9.37
  • Analyst Decision
  • JQC
  • BVS Strong Buy
  • Analyst Count
  • JQC 0
  • BVS 4
  • Target Price
  • JQC N/A
  • BVS $15.00
  • AVG Volume (30 Days)
  • JQC 714.6K
  • BVS 404.4K
  • Earning Date
  • JQC 01-01-0001
  • BVS 03-11-2025
  • Dividend Yield
  • JQC 11.13%
  • BVS N/A
  • EPS Growth
  • JQC N/A
  • BVS N/A
  • EPS
  • JQC N/A
  • BVS N/A
  • Revenue
  • JQC N/A
  • BVS $573,280,000.00
  • Revenue This Year
  • JQC N/A
  • BVS N/A
  • Revenue Next Year
  • JQC N/A
  • BVS $6.09
  • P/E Ratio
  • JQC N/A
  • BVS N/A
  • Revenue Growth
  • JQC N/A
  • BVS 11.89
  • 52 Week Low
  • JQC $4.82
  • BVS $3.90
  • 52 Week High
  • JQC $5.65
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • JQC 35.68
  • BVS 45.59
  • Support Level
  • JQC $5.27
  • BVS $8.78
  • Resistance Level
  • JQC $5.58
  • BVS $9.98
  • Average True Range (ATR)
  • JQC 0.07
  • BVS 0.43
  • MACD
  • JQC -0.00
  • BVS -0.03
  • Stochastic Oscillator
  • JQC 22.58
  • BVS 43.83

About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: